Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15.09. | Beyond Politics: Payer Solutions for Fluoride-free Communities | ||
15.09. | What's Next for Walgreens Following its Private Equity Sale? | ||
14.09. | Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for $800M | ||
14.09. | Industry Groups Warn CMS' 2026 Fee Schedule Could Undermine Value-Based Care | ||
14.09. | How Pharma Marketers Can Prepare for Trump's 200% Tariff Threat | ||
14.09. | Microplastics Are in Our Blood - Why Aren't Federal Regulators Acting? | ||
12.09. | Goodpath Rakes In $18M for Chronic Condition Platform | ||
12.09. | Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval | ||
12.09. | Health Plan Leaders Reveal Underreported Medicaid Challenges, Anticipated Risks, and Solutions | ||
12.09. | Why Traditional EMRs Are Holding Healthcare Back | ||
12.09. | Your Guide to the Hottest Topics on AI in Healthcare in Dallas Next Week at INVEST Digital Health | ||
12.09. | Headway Launches Enhanced EHR Platform for Mental Health Providers | ||
11.09. | Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care | ||
11.09. | LB Pharma Pushes the Biotech IPO Window Open, Bagging $285M for Key Schizophrenia Drug Trial | ||
11.09. | Healthcare's Data Orchestra: Why Rising Drug Denials Signal a Need for Better Coordination | ||
11.09. | Debunked Episode 19: Turmoil at the CDC, Epic's AI Strategy | ||
11.09. | Racing the Clock: The Life-or-Death Power of Early Drugs-of-Abuse Diagnostics in the Emergency Department | ||
11.09. | Positioning & Distribution Will Determine the Winning Healthcare AI Startups, Investor Says | ||
11.09. | A Third of Employers Can't Access Medical Claims Data from Vendors, Survey Finds | ||
11.09. | FDA Nod for J&J's Drug/Device Treatment Gives Bladder Cancer Patients Another Option | ||
10.09. | The Hidden Cost of Healthcare AI: Why Premium Prices Don't Equal Premium Results | ||
10.09. | Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare | ||
10.09. | Strive Health Secures $550M to Advance Value-Based Kidney Care Model | ||
09.09. | Corewell Health Touts Success of Virtual Lifestyle Medicine Program with Nudj Health | ||
09.09. | Novartis's $1.4B Tourmaline Acquisition Brings Heart Drug That Could Rival Novo Nordisk, CSL Meds |